Dissolution testing - EU edition MasterClass

07-08 March, 2023

A number of aspects in the paper are also relevant for sustained and extended release dosage forms.

Dissolution testing - EU edition MasterClass

This topic is not only of central importance in the context of generic drug development, but also in particular in the case of changes in the physicochemical properties of the active substance, in the manufacture and/or composition of products, and in the case of site transfers.

 

07-08 March, 2023, Virtual

Time Zone: UTC/GMT+1 /CET

GET THE AGENDA NOW

Pharma Online Masterclass

Overview

 

Changes in manufacturing or even a “site transfer” are imminent and the authority expects you to justify why you do not need a new biostudy as part of the submission of the change. This can only be done based on comparative drug release data with a process that meets the current requirements. Immediate release products in Europe are now expected to follow the guidance in the EMA paper “Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action” (EMA/CHMP/CVMP/QWP/336031/2017) when developing methods and setting release specifications for market release. The paper sets out, fromtheperspectiveofEUregulators, thestateof theart inthedevelopmentofappropriate drug release procedures in quality control for rapid-release generic oral solid dosage forms and how specifications for release and duration should be set and justified. An important area of tension that arises is the different approach to demonstrating pharmaceutical equivalence for biosolids and routine batch release testing. A number of aspects in the paper are also relevant for sustained and extended release dosage forms. This applies equally to human and veterinary medicinal products. The topic is not only of central importance in the context of generic drug development, but also in particular in the case of changes in the physicochemical properties of the active substance, in the manufacture and/or composition of products, and in the case of site transfers. The latter points also apply to innovator products. Production and site transfers.

 

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #dissolutiontesting

who should attend imgRECOMMENDATION

Who should attend?


• Persons involved in dissolution method development

• QC laboratory staff for testing of solid oral dosage forms

• RA-CMC teams implementing analytical, validation and release testing data into the dossier

• Quality assurance staff with focus on analytical laboratory

• Head of quality control

• EU Qualified Persons

Testimonial

Our success stories

"High attention to detail in course content and very well delivered"

Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom

Our success stories

"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"

Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland

Our success stories

"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"

Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany

About GLC

Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today it’s an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.

know more >

10+

Years of experience

299

Events organized

3,410

Speakers

17,761

Attendees

REQUEST AGENDA FORM
Download Full Agenda
Get the Agenda now for Additional Information, Detailed Program and Pricing

Name
Corporate email
Corporate phone
From where did you heard about the event?
Name of the GLC Representative (optional)
E-mail consent
Privacy Policy

Other events you may like

Process Validation for Biotechnological Products - EU edition MasterClass

Process Validation for Biotechnological Products - EU edition MasterClass

07-08 February, 2023

This MasterClass will provide best understanding on how process validation for biotechnological processes, which is the collection and evaluation of data from the process design stage through commercial production.

Good Clinical Practices - US edition MasterClass

Good Clinical Practices - US edition MasterClass

07-08 February, 2023

This online practical course provides an in-depth understanding of GCP requirements and their practical implications.

Pharma Good Distribution Practice - EU edition MasterClass

Pharma Good Distribution Practice - EU edition MasterClass

09-10 February, 2023

This informative training with two RP’s / RPI’s for all things GDP.

10+

Years of experience

299

Events organized

3,410

Speakers

17,761

Attendees

You’re in good company

deutsche bank logo e on logo kpmg logo merck logo roche logo siemens logo

Testimonial

Our success stories

"High attention to detail in course content and very well delivered"

Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom

Our success stories

"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"

Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland

Our success stories

"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"

Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany